Use of Prenatal Exome Sequencing: Opinion Statement of the French Federation of Human Genetics Working Group
Prenatal Diagnosis · 2025
DOI: 10.1002/pd.6692 ↗At a glance
Übersichtsarbeit in Prenatal Diagnosis, 2025. Written by Guillaume Cogan and 10 co-authors. Institution: Département de génétique médicale, AP-HP Sorbonne Université, UF de Neurogénétique Moléculaire et Cellulaire, Hôpital Pitié-Salpêtrière, Paris, Franc…. Major MEDLINE topics: Exome Sequencing, Prenatal Diagnosis. Cited 15 times so far (Crossref); 60 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Federation Française de Génétique Humaine.
Abstract (original language)
Objective
Prenatal whole exome sequencing (pES) is increasingly prescribed for fetuses with ultrasound anomalies. Starting from the local French prenatal medicine practice, healthcare system and legal landscape, we aimed to address the broad medical and ethical issues raised by the use of pES for women and couples as well as for prenatal care providers.
Method
The French Federation of Human Genetics established a working group composed of clinicians and biologists from all over France to discuss pES challenges. A literature review was also performed.
Results
We emphasize the importance of non‐directive information that helps couples make a decision that is consistent with their personal values and ideas. We address the difficulty of obtaining informed consent that respects the couple's autonomy, despite the complexity of the information and regardless of their level of education and cultural background. We address whether variants of uncertain significance and unsolicited results should be reported. We emphasize the need for national harmonization of access to pES and the need for multidisciplinary meetings in complex situations. We point out that the specific French context of healthcare financing and the French law have a major influence on medical care organization and support for couples. The outcome of the working group is the development of 12 proposals.
Conclusion
This opinion statement, dedicated to prenatal care providers worldwide although linked to the French context, will provide food for thought and assist them in understanding the complexity and implications of pES.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Département de génétique médicale, AP-HP Sorbonne Université, UF de Neurogénétique Moléculaire et Cellulaire, Hôpital Pitié-Salpêtrière, Paris, France.
- Univ Brest, Inserm, EFS, UMR 1078, GGB, Brest, France.
- CHRU Brest, service de génétique, laboratoire de génétique chromosomique, Brest, France.
- Service de génétique génomique et procréation, Hôpital Couple-Enfant, CHU Grenoble, Grenoble, France.
- Département de génétique - UF de fœtopathologie, CHU Robert Debré, Paris, France.
- Université Montpellier, Inserm U1183, centre de référence anomalies du développement et syndromes malformatifs, Service de génétique clinique, CHU Montpellier, Montpellier, France.
ORCID profiles: Guillaume Cogan, François Vialard, Alexandra Benachi
Funding
- Federation Française de Génétique Humaine
Cite
APA
Cogan, G., Troadec, M. B., Devillard, F., Saint-Frison, M. H., Geneviève, D., Vialard, F., Rial-Sebbag, E., Héron, D., Attie-Bitach, T., Benachi, A., & Saugier-Veber, P. (2025). Use of Prenatal Exome Sequencing: Opinion Statement of the French Federation of Human Genetics Working Group. Prenatal Diagnosis. https://doi.org/10.1002/pd.6692
Vancouver
Cogan G, Troadec MB, Devillard F, Saint-Frison MH, Geneviève D, Vialard F, et al. Use of Prenatal Exome Sequencing: Opinion Statement of the French Federation of Human Genetics Working Group. Prenatal Diagnosis. 2025. doi:10.1002/pd.6692
BibTeX
@article{Cogan2025,
author = {Cogan, Guillaume and Troadec, Marie-Bérengère and Devillard, Françoise and Saint-Frison, Marie-Hélène and Geneviève, David and Vialard, François and Rial-Sebbag, Emmanuelle and Héron, Delphine and Attie-Bitach, Tania and Benachi, Alexandra and Saugier-Veber, Pascale},
title = {Use of Prenatal Exome Sequencing: Opinion Statement of the French Federation of Human Genetics Working Group},
journal = {Prenatal Diagnosis},
year = {2025},
doi = {10.1002/pd.6692}
}
EUVIMED